Depression: Gaps & Guideposts
Methodology and Acknowledgements
Harris Interactive conducted the survey for NAMI online between Sept. 29-Oct. 7, 2009. Participants included 1,015 persons who did not know anyone diagnosed with depression, 513 persons living with depression and 263 caregivers of a family member or significant other who was diagnosed with depression.
The survey was 20 minutes in length and contained approximately 30 questions. Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them in line with their actual proportion in the population.
NAMI thanks the many individuals living with depression and caregivers who participated in the depression survey. Their willingness to share their stories and experiences is insightful and beneficial to many.
NAMI is grateful to the members of the Advisory Committee who contributed many hours developing the scope of the survey and helping to integrate the findings into an informing outcome.
Along with NAMI staff who served on the Advisory Committee, additional NAMI staff who contributed to the initiative include Bob Carolla, director of media relations; Charles Harmon, director of external relations; Don Lamm, director of Web services and Courtney Reyers, publications manager.
NAMI Advisory Committee Members:
Douglas Bradley has lived with depression for 20 years. He works as a information and referral associate for the NAMI HelpLine. He serves on the Arlington County Local Human Rights Committee.
Ken Duckworth, M.D., is a clinical psychiatrist and assistant professor at Harvard University Medical School and serves as medical director for NAMI. Dr. Duckworth has extensive experience serving as the acting commissioner and medical director of Massachusetts Department of Mental Health.
Elizabeth R. Edgar, M.S.S.W., is a senior policy analyst at NAMI. Ms. Edgar has worked in the mental health field since 1975 as a community mental health agency service provider and manager, state department of mental health community services and housing administrator, and national technical assistance project director. Further understanding of treatment needs and the family perspective comes from her relationship with her 33-year-old daughter who is recovering from a severe mental illness.
Michael Fitzpatrick, M.S.W., is executive director of NAMI. He has nearly 35 years of experience in the public mental health sector and served as the house chair of the Health and Human Services Committee in the Maine State Legislature from 1994-96. Mr. Fitzpatrick has served on numerous community, government and nonprofit boards and expert panels. He presently serves on the board of Resource for Advancing Children's Health (REACH) Institute. Mr. Fitzpatrick has a master's in social work from Boston College.
Katrina Gay is director of communications for NAMI where she oversees the organization's strategic and operational communications initiatives. Her career has encompassed a variety of communications and public relations specialties. Ms. Gay serves on the advisory board of Esperanza magazine. She was educated at Texas A&M University and the University of Houston, where she studied economics.
Kimberly Meltzer. M.P.P., is a policy research associate for NAMI where she provides policy research and data analysis on a broad range of mental health issues, as well as expertise in writing for a range of materials and publications. Ms. Meltzer has a master of public policy degree from Pepperdine University and a B.A. from Illinois Wesleyan University.
Anand Pandya, M.D., is the Vice-Chair of Psychiatry at Cedars-Sinai Medical Center. He is a nationally recognized expert in disaster psychiatry, having co-founded the nonprofit Disaster Psychiatry Outreach. He received the Kenneth Johnson Memorial Book Award for Disaster Psychiatry: Intervening when Nightmares Come True. He is on the NAMI Scientific Advisory Panel and has served as the national President.
Charles Schultz, M.D., is the Hastings endowed chair and head of the department of Psychiatry at the University of Minnesota. He received his medical degree and psychiatric residency training from the University of California, Los Angeles. He became a clinical associate in the neuropsychopharmacology section of the National Institute of Mental Health (NIMH) following his residency. At the University of Minnesota, Dr. Schultz' work has continued in brain imaging studies of both people with schizophrenia and borderline personality disorder as well as in treatment studies.
This project was made possible with support from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co. and Wyeth.
NAMI does not endorse or promote any specific medication, treatment, product or service.
Overview | Summary of Findings |
Summary of Findings Pt. 2 |
Methodology and Acknowledgements